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The hantavirus nucleocapsid (N) protein is an important immunogen that stimulates a strong and
cross-reactive immune response in humans and rodents. A large proportion of the response to N protein
has been found to target its N-terminus. However, the exact nature of this bias towards the N-terminus
is not yet fully understood. We characterized six monoclonal antibodies (mAbs) against the N protein of
Montano virus (MTNV), a Mexican hantavirus. Five of these mAbs recognized eight American
hantaviruses and six European and Asian hantaviruses, but not the Soricomorpha-borne Thottapalayam
hantavirus. The N protein-reactive binding regions of the ﬁve mAbs were mapped to discontinuous
epitopes within the N-terminal 13–51 amino acid residues, while a single serotype-speciﬁc mAb was
mapped to residues 1–25 and 49–75. Our ﬁndings suggest that discontinuous epitopes at the
N-terminus are conserved, at least in rodent-borne hantaviruses, and that they contribute considerably
to N protein cross-reactivity.
& 2012 Elsevier Inc. All rights reserved.Introduction
The hantavirus (family Bunyaviridae) genome consists of three
RNA segments of negative-sense polarity, Large (L), Medium (M),
and Small (S), encoding the viral polymerase, envelope glycopro-
teins, and nucleocapsid (N) protein, respectively (Schmaljohn et al.,
1986). Hantaviruses are normally carried by persistently infected
rodents, from which humans are believed to acquire the infection
primarily through the inhalation of virus-contaminated excreta;
however, human-to-human transmission has also been reported
(Martinez et al., 2005). Infection with American hantaviruses causes
hantavirus pulmonary syndrome (Hjelle et al., 1994), whereas the
viruses originating from Europe and Asia cause hemorrhagic fever
with renal syndrome (Avsic-Zupanc et al., 1992).
European and Asian (i.e., Old World) hantaviruses known to
cause illness in humans include Hantaan virus (HTNV), Dobrava
virus (DOBV), Puumala virus (PUUV), Seoul virus (SEOV), and Amurll rights reserved.
Kariwa).virus (AMRV). Others, such as Tula virus (TULV) and Hokkaido virus
(HOKV), have not been associated with human disease. American
(i.e., NewWorld) hantaviruses, such as Sin Nombre virus (SNV), New
York virus (NYV), Black Creek Canal virus (BCCV), and Bayou virus
(BAYV), are known human pathogens. In South America, viruses so
far linked with human illness include Andes virus (ANDV), Laguna
Negra virus (LANV), and Lechiguanas virus (LECV). Maporal virus
(MAPV), Rio Mamore virus (RIOMV), have not been associated with
human disease (Jonsson et al., 2010).
Hantaviruses detected in Mexico include EL Moro Canyon
virus (ELMCV) (Torrez-Martinez et al., 1995) and, more recently,
Playa de Oro virus (OROV) (Chu et al., 2008). In our recent wild
rodent epidemiological survey in Guererro and Morelos States,
Mexico, we identiﬁed virus RNA of three distinct hantaviruses,
currently designated as Montano virus (MTNV), Carrizal virus
(CARV), and Huitzilac virus (HUIV), the pathogenicity of which to
humans is still unknown (Kariwa et al., 2012).
The hantavirus N protein, in addition to being the most abundant
viral protein, plays key roles in hantavirus infection, including
encapsidation, binding of the viral RNA genome (Severson et al.,
2001; Xu et al., 2002), and initiation of the transcription and
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The N-terminus of the N protein has been found to be necessary for
other viral processes, including oligomerization and N–N interactions
(Alminaite et al., 2006; Kaukinen et al., 2001). The N protein is a
frequently used antigen for detecting hantavirus antibodies, because
it is highly conserved and provokes a strong immune response in
humans and mice (Bharadwaj et al., 2000; de Carvalho Nicacio et al.,
2002). Although antigenic determinants have been detected over the
entire length of the N protein, the strongest response is directed
toward the N-terminus (Alfadhli et al., 2002; Boudko et al., 2007;
Elgh et al., 1996; Jenison et al., 1994; Lundkvist et al., 1996), which
contributes substantially to the overall cross-reactive immune
response (Lindkvist et al., 2007; Tischler et al., 2008). As such, deletion
of the N-terminus from the protein permits the generation of antigens
with serotype-speciﬁc applications (Koma et al., 2010; Li et al., 2006;
Morii et al., 1998; Tischler et al., 2008).
Monoclonal antibodies (mAbs) are useful tools for studying
hantavirus antigenic characteristics due to their speciﬁcity. So far,
several studies have attempted to generate mAbs with desired
speciﬁcities. For example, the immunization of mice with more
than one antigen or the use of virus core particle delivery systems
have generated mAbs with relatively broad cross-reactivity
(Geldmacher et al., 2004; Kucinskaite-Kodze et al., 2011). A large
proportion of this response was shown to arise from the N-ter-
minus. Evidence gathered through crystal structural analysis and
nuclear magnetic resonance (NMR) spectroscopic predictions
have revealed that the N-terminus assumes a coiled-coil a-helix
conformation (Boudko et al., 2007; Wang et al., 2008). However,
the role of this domain in inducing strong and cross-reactive
responses remains to be thoroughly investigated.
To broaden our understanding of the antigenic properties of
the N protein of Mexican hantavirus, we generated and charac-
terized six mAbs against MTNV N protein expressed in bacteria.
Five of the six mAbs showed a strong and broad spectrum of
reactivity to both American and Eurasian rodent-borne hanta-
viruses (reactivity to the Soricomorpha-borne Thottapalayam
virus [TPMV] was not observed). The binding regions of the ﬁveFig. 1. Reactivity of mAbs to whole hantavirus N protein fused with NuSA (120 kDa)
control antigen and (B) reactivity of 2H10, 7E6 and G8B4 to the hantavirus N proteinscross-reactive mAbs were mapped to the N-terminal 13–51
amino acids (aas) of the N protein, with their activity apparently
dependent on the preservation of the integrity of the N-terminal
domain. Our ﬁndings suggest that the N protein coiled-coil
a-helix domain possesses conformational epitopes that contri-
bute signiﬁcantly to cross-reactivity, at least in rodent-borne
hantaviruses.Results
mAb production and isotyping
Six hybridoma clones (2H10, 9E5, 10G5, 2F11, 7E6, and G8B4)
that had a strong and speciﬁc reaction to MTNV N protein on
enzyme-linked immunosorbent assay (ELISA) were established.
All six mAbs recognized the hantavirus N protein by Western
blotting. All clones were of the IgG1 Kappa subclass except for
10G5, which belonged to IgG2a (Supplementary Table 1).
Reactivity of the mAbs to bacteria- and baculovirus-expressed
hantavirus N protein
To determine the extent of mAb reactivity to different hanta-
viruses, several N proteins expressed in bacteria or a baculovirus
system were tested by ELISA. The mAbs recognized bacterially-
expressed whole N proteins of homologous MTNV and two other
Mexican hantaviruses (HUIV and CARV), as well as SNV (Fig. 1A).
The reactivity of the mAbs to the European and Asian hantavirus
N antigens was varied. For example, mAb 2H10, 10G5 and 7E6
recognized and reacted with nearly all of the antigens, including
ANDV, LANV, MAPV, HTNV, SEOV, AMRV, PUUV, TULV, and HOKV
[AB010731]. All of the mAbs except G8B4 also reacted with the N
proteins of PUUV, TULV and HOKV whereas 2F11 did not
recognize the HTNV, AMRV and SEOV antigens and 9E5 did not
react with AMRV and SEOV. G8B4 showed speciﬁcity to North
American hantaviruses, reacting only with SNV and the three. (A) ELISA reactivity of mAbs to 15 hantavirus N proteins and NuSA as a negative
on Western blotting.
Table 1
Reactivities of mAbs to N proteins of hantaviruses expressed in baculovirus in ELISA.
mAb North America South America Europe and Asia
MTNV CARV HUIV SNV BCCV ANDV LANV MAPV HTNV SEOV PUUV TULV TPMV
2H10 þa þ þ þ þ þ þ þ þ þ þ þ b
9E5 þ þ þ þ þ þ þ þ þ þ þ þ 
10G5 þ þ þ þ þ þ þ þ þ þ þ þ 
2F11 þ þ þ þ þ þ þ þ   þ þ 
7E6 þ þ þ þ þ þ þ þ þ þ þ þ 
G8B4 þ            
a ELISA OD: Z0.2.
b ELISA OD: o0.2.
Table 2
Reactivities of mAbs to N proteins of hantaviruses expressed in Vero E6 cells on IFA.
Region North America South America Europe and Asia
N protein MTNV CARV HUIV SNV ANDV LANV MAPV HTNV SEOV PUUV TULV TPMV
2H10 þa þ þ þ þ þ þ þ þ þ þ b
9E5 þ þ þ þ þ þ þ þ þ þ þ 
10G5 þ þ þ þ þ þ þ þ þ þ þ 
2F11 þ þ þ þ þ þ þ   þ þ 
7E6 þ þ þ þ þ þ þ þ þ þ þ 
G8B4 þ þ þ þ  þ þ    þ 
E5G6c þ  þ þ þ þ þ þ þ þ þ þd
a IFA titer: Z1:100.
b IFA titer: o1:100.
c Hybridoma culture supernatant.
d TMPV N was manipulated to add binding ability to E5G6 (Okumura et al., 2007).
Table 3
Reactivities of mAbs to authentic N proteins of European and Asian hantaviruses
in IFA.
mAb Rodent-borne Soricomorpha-borne
HTNV SEOV PUUV TULV TPMV
2H10 þa þ þ þ b
9E5 þ þ þ þ 
10G5 þ þ þ þ 
2F11  þ þ þ 
7E6 þ þ þ þ 
G8B4    þ 
E5G6c þ þ þ þ þd
a IFA titer: Z1:100.
b IFA titer: o1:100.
c
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with BCCV antigen. The reactivity of representative mAbs to
bacterially-expressed hantavirus N proteins was conﬁrmed by a
strong response on Western blotting. None of the mAbs reacted
with NuSA, a negative control antigen (Fig. 1B).
We also examined the reactivity to baculovirus-derived N
proteins of various hantaviruses (Table 1). Four of the mAbs
(2H10, 9E5, 10G5, and 7E6) recognized baculovirus-derived anti-
gens of North (MTNV, CARV, HUIV, SNV, and BCCV) and South
American hantaviruses (ANDV, LANV, and MAPV) as well as the
European and Asian viruses (HTNV, SEOV, PUUV, and TULV) but
not TPMV. The mAb 2F11 did not react with HTNV or SEOV
antigen. G8B4 reacted with homologous MTNV N antigen but did
not react with other N proteins examined, including the closely
related CARV, HUIV or SNV antigen.Hybridoma culture supernatant.
d Anti-TPMV serum.Reactivity of the mAbs to native hantavirus N proteins expressed in
Vero E6 cells by indirect immunoﬂuorescence antibody assay (IFA)
The reactivity of the mAbs to native antigens was further
assessed by IFA in transfected and infected Vero E6 cells. The mAb
reactivity pattern was consistent between the N proteins in both
transfected and infected cells. As summarized in Table 2, the ﬁve
cross-reactive mAbs strongly recognized nearly all American,
European, and Asian hantavirus N proteins tested. However,
2F11 did not react with the HTNV or SEOV antigens, while G8B4
only reacted with the N proteins of MTNV, CARV, HUIV, SNV, and
weakly to LANV, MAPV and TULV. A manipulated TPMV N protein
to add the binding ability to E5G6 was used to conﬁrm expression
(Okumura et al., 2007).
The reactivity on IFA was veriﬁed by applying the mAbs to
authentic hantavirus N protein in virus-infected cells, in which a
response similar to that in transfected cells was observed(Table 3). None of the mAbs reacted with TPMV N protein
(Tables 2 and 3).Determination of the binding regions using truncated MTNV N
protein
Given the observed propensity of the mAbs for cross-reactivity
to different hantavirus N proteins, we sought to deﬁne the regions
of the N protein targeted by each mAb. Initially, we applied the
mAbs to truncated MTNV N proteins (Fig. 2A). The mAbs recog-
nized the whole N protein (N1–428), N1–80, and N1–150, but not
N46–125, N125–275, or N250–428 (Table 4), suggesting that all
of the epitopes were located within the ﬁrst 80 aa residues at the
N-terminus.
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Fig. 2. Diagrammatic representation of MTNV N protein for mapping the epitopes recognized by the mAbs. (A) Full-length N protein and the truncated mutants, N protein
mutants with 15aa deletions within the ﬁrst 100 aas at the N-terminus. Substitution of alanine for proline at residue 36 (P36A) in full-length MTNV N protein. The n and t
represent the N fusion protein for antigens expressed in bacteria. The asterisk (n) indicates the position of the alanine substitution in the N-terminus. (B) Assessment of the
expression levels of the various N terminus deletion mutant constructs to the six mAbs compared to control mAb E5G6 with a binding region located outside the
N-terminus.
Table 4
Reactivities of mAbs to bacterially-expressed full-length and truncated N proteins
of MTNV.
mAb MTNV N protein
N1–428 N1–80 N1–150 N46–125 N125–275 N250–428
2H10 þa þ þ b  
9E5 þ þ þ   
10G5 þ þ þ   
2F11 þ þ þ   
7E5 þ þ þ   
G8B4 þ þ þ   
a ELISA OD: Z0.2.
b ELISA OD: o0.2.
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fragments
To reﬁne the binding regions of the mAbs within the N-termi-
nus, we constructed and expressed 15 aa-deleted fragments of
MTNV N protein covering residues 1–99 with three overlapping
residues (Fig. 2A) and analyzed their reactivity by IFA (Table 5).
Two major mAb patterns of reactivity were observed. Five mAbs
(2H10, 9E5, 10G5, 2F11, and 7E6) recognized D1–15-deleted N
but lost reactivity to D25–39 and D37–51 N, although 2F11 and
10G5 reacted weakly with D13–27 N. On the other hand, G8B4
showed a different response pattern: recognition was abolished
by the D1–15 and D13–27 deletions, but restored by D25–39 and
D37–51 N successive deletions, while D49–63 and D61–75 N
Table 5
Mapping of mAbs-binding regions to N protein of MTNV mutant N lacking 15 amino acids were expressed in Vero E6 cells and used as antigen for IFA test.
mAb MTNV N Protein Binding site (aa)
N1–428 D1–15 D13–27 D25–39 D37–51 D49–63 D61–75 D73–87 D85–99
2H10 þa þ b   þ þ þ þ 13–51
9E5 þ þ    þ þ þ þ 13–51
10G5 þ þ þ   þ þ þ þ 25–51
2F11 þ þ þ   þ þ þ þ 25–51
7E6 þ þ    þ þ þ þ 13–51
G8B4 þ   þ þ   þ þ 1–27, 49–75
E5G6c þ þ þ þ þ þ þ þ þ 166–175
a IFA titer: Z1:100.
b IFA titer: o1:100.
c Hybridoma culture supernatant.
Fig. 3. Evaluation of mAb reactivity to wild-type MTNV N protein (wt) and P36A N protein as a 293T cell antigen lysate. (A) Indirect capture ELISA of biotinylated 2H10
(0.690 mg/mL), 7E6 (0.166 mg/mL), and G8B4 (0.138 mg/mL). (B) Assessment of the reactivity of the six mAbs to P36A N protein mutant and wild-type MTNV N protein
(wt) and SNV N protein as a positive control (PC) on Western blotting. (C) Assessing the expression levels of the mutant N protein compared to the wt form using mAb
E5G6 with a binding region located outside the N-terminus, empty vector as a negative control (NC).
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87 and D85–99 N. Evaluation of these deleted constructs of MTNV
N protein in Western blotting using mAb E5G6 showed compar-
able levels of expression (Fig. 2B).
Reactivity of the mAbs to MTNV N proline-36 (Pro36) substituted
with alanine by IFA, ELISA, and Western blotting
To assess the role of the N-terminal coiled-coil a-helix con-
formation in mAb reactivity, Pro36 in the full-length N protein
was replaced with alanine (P36A). When examined by IFA in
transfected cells, all of the mAbs reacted with the P36A mutant;
compared with wild type, the intensity varied but was weaker
overall, especially for mAb 2H10 (data not shown). A similarpattern was observed on capture ELISA and Western blotting
using a 293T cell antigen lysate (Fig. 3A and B). Differential
expression of the wild-type and P36A mutant proteins as the
cause of the disparity was assessed using mAb E5G6, which had
an epitope located outside the N-terminal domain that showed
equal band sizes on Western blotting, suggesting comparable
levels of expression of the two constructs (Fig. 3C).
Mapping of the topological relationships by a competitive binding
assay
We performed a competitive binding capture ELISA to deter-
mine the topological relationships of the epitopes within the
N-terminus using full-length MTNV N protein (Fig. 4). The assay
Fig. 4. Competitive ELISA of the six mAbs showing the inhibition of biotin-labeled mAbs on MTNV N protein using 10-fold serial dilutions of unlabeled mAbs. (A) Example
of the complete inhibition pattern of mAb 2H10 to the other four mAbs (9E5, 10G5, 7E6, and 2F11), except for G8B4, which exhibited partial inhibition. (B) Reverse set up
of G8B4 competitor (unlabeled) showing the complete inhibition to homologous labeled G8B4 and the absence of inhibition of the other ﬁve mAbs.
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Five mAbs (2H10, 9E5, 10G5, 2F11, and 7E6) showed complete
two-way inhibition, and, as anticipated, G8B4 showed partial
inhibition (50–60%) when the ﬁve other mAbs were used as
competitors (Fig. 4A). However, when the format was reversed
(i.e., with G8B4 as the competitor [unlabeled]), no inhibition was
observed in the other ﬁve mAbs (Fig. 4B), consistent with our
deleted mutant epitope mapping results that showed partial
overlap between G8B4 and the other mAbs (Table 5).Discussion
The generation of mAbs for detecting hantaviruses is an
important approach to obtain information on the antigenic
properties of hantaviruses, especially in Mexico, because few
hantavirus-related studies have been conducted so far. In this
study, we generated and characterized six mAbs directed against
the MTNV N protein that had extended cross-reactivity to a wide
range of rodent-borne hantavirus N proteins expressed in bac-
teria, baculovirus, and mammalian systems. The region of the N
protein responsible for eliciting this strong cross-reactivity was
mapped to discontinuous epitopes within the N-terminus.
As is common with hantaviruses, we observed that all of the
mAbs targeted the N-terminus, a region known to be immuno-
dominant. A preliminary assessment of mAb reactivity on ELISA
indicated a relatively wide spectrum of cross-reactivity to other
hantavirus antigens. Additionally, we observed that all of the
mAbs recognized SDS-treated antigens on Western blotting
(Fig. 1B). Because the MTNV N protein used for mouse immuniza-
tion was expressed in Escherichia coli, our initial concern was that
these cross-reactive antigenic determinants could be bacteria-
speciﬁc and absent from other systems or authentic virus N
protein. Thus, we examined the reactivity of the mAbs to
hantavirus N proteins expressed in other systems.
Although a comprehensive comparison of the antigens could
not be made between the bacterial and baculovirus expression
systems, the results of the ﬁve mAbs (2H10, 9E5, 10G5, 2F11, and
7E6) were consistent. While G8B4 reactivity was restricted
mainly to the North American hantaviruses, in bacterial expres-
sion, G8B4 reacted with MTNV, CARV, HUIV, and SNV but in
baculovirus expression, only homologous MTNV was positive. Thereason why the reactivity of G8B4 was lost in baculovirus system
is not clear. It is likely that the bacterial expression and other
expression systems preserve the epitope conformation. Moreover,
mAb 7E6 recognized all of the European and Asian hantaviruses
examined, at least to some degree. Furthermore, these differences
appeared to have a greater effect on the ability of the mAbs to
react with heterologous antigens, such as the European and Asian
viruses. As noted, when mAb reactivity to native N protein was
examined in mammalian cells by IFA, four mAbs strongly recog-
nized antigens of all the hantaviruses considered (Table 3). This
recognition of N protein in virus-infected cells conﬁrmed that the
epitopes eliciting the cross-reactive B-cell response to bacterially-
expressed antigen were authentic. Additionally, the failure of the
mAbs to recognize authentic TPMV antigen showed that the
target epitopes may assume a different conformation in Sorico-
morpha-borne hantavirus N protein or be absent altogether
(Yadav et al., 2007).
The reactivity to truncated MTNV N fragments highlights the
immunodominant nature of the protein’s N-terminus (Elgh et al.,
1996; Lundkvist et al., 1996). Moreover, the failure to react with
the fragment N46–125 is worth noting because it suggests the
need for the complete stretch of N-terminal residues. These
results are consistent with previous ﬁndings showing that the
ﬁrst 100 aas comprise the immunodominant region of hantavirus
N protein (Geldmacher et al., 2004; Gott et al., 1997). Further
examination of mAb reactivity using N-terminus-deleted mutants
shed more light on the binding properties. We found that those
mAbs with the highest level of cross-reactivity (2H10, 9E5, 2F11,
10G5 and 7E6) bound to residues 13–51, a region previously
shown to induce a cross-reactive immune response in hantavirus-
infected humans (Jenison et al., 1994). Our initial speculation was
that the mAbs were targeting linear epitopes because they
recognized SDS-treated antigens strongly on Western blotting.
However, an evaluation of reactivity using the deleted mutants
suggested that the mAbs could be targeting non-linear or con-
formational epitopes (Table 5).
To further explore this observation, given that the N-terminus
forms a coiled-coil a-helix conformation, we hypothesized that if
attachment of the mAbs involved straddling between the N
protein helices, substituting the residue Pro36 would interfere
with reactivity. A previous study demonstrated that the substitu-
tion of Pro36 destabilized the coiled–coiled conformation but
Fig. 5. Binding regions of the mAbs, as determined using truncated and deleted N protein mutants. (A) Schematic view of the residues (aas 1–100) at the MTNV N protein
N-terminus recognized by the six mAbs. The mAb and residues necessary for reactivity included: G8B4, (aas 1–27 and 49–75) open bar; 2H10, 9E5, and 7E6 (aas 13–51),
gray bar; and 2F11 and 10G5 (aas 25–51), broken lines. (B) Alignment of the N-terminal residues (aas 1–80) from the hantaviruses used in the analysis, showing the
binding regions of G8B4 (I and II) and 2H10, 9E5, 10G5, 2F11, and 7E6 (III).
N. Saasa et al. / Virology 428 (2012) 48–5754preserved the secondary a-helix structure (Wang et al., 2008). For
this experiment, Pro36 was substituted with alanine to uncouple
the helix–helix interaction, while, as much as possible, maintain-
ing the secondary structure of the helix. The reactivity of the
mAbs to the mutant was lower than that to wild type, suggesting
that the substitution destabilized the conformation of the
N-terminal domain. Although we changed a single residue,
Lindkvist et al. (2008) found that by substituting four residues
(aas 34–38) instead, nephropathia epidemica patient polyclonal
sera reactivity to a heterologous antigen was signiﬁcantly
affected. This indicates that these residues are involved in indu-
cing cross-reactivity, directly as part of the epitope or indirectly,
by conferring conformational stability to the protein.
A competitive ELISA conﬁrmed that ﬁve of the six mAbs
recognized similar regions. A comparison of the speciﬁc reactivity
of G8B4 (aas 1–27 and 49–75) to the ﬁve other mAbs suggested
the presence of broadly cross-reactive conformation-dependent
epitopes within aas 13–51 at the N-terminus (Fig. 5A).
Although the exact nature of the effect of the deletions
remains undetermined, the complete loss of reactivity of the
mAbs to the mutant N protein due to deletions between aas 13
and 51 at the N-terminus suggests that conformational integrity
of this region is necessary for antibody recognition. The residues
necessary for cross-reactivity could not be deﬁned due to the
sequence diversity across the hantaviruses examined (Fig. 5B).
Therefore, these cross-reactive mAbs may be useful probes for
structure–function relationship studies.
In this study, we showed that within the N-terminus there are
conformation-dependent epitopes responsible for inducing exten-
sive cross-reactivity within rodent-borne hantaviruses. Thesedata suggest that although the primary structure of the hanta-
virus N protein may vary, there are highly conserved antigenic
determinants apparently common to rodent-borne hantaviruses,
thus pointing to similar structure and function mechanisms.Methods
Cloning of the full-length genes and truncated and deleted mutants
For the expression of full-length N protein in E. coli (strain
AD494 pLysS), cDNAs for the entire N protein open reading frame
from MTNV, CARV, and HUIV (Kariwa et al., 2012) and SNV, kindly
supplied by Dr. C. J. Peters (University of Texas Medical Branch,
Galveston, TX, USA), BCCV (Rollin et al., 1995), ANDV (Reynolds
et al., 2007), LANV (Johnson et al., 1997), MAPV (Fulhorst et al.,
2004), HTNV strain 76–118 (Lee et al., 1982), AMRV (Lokugamage
et al., 2004), SEOV (Kitamura et al., 1983), PUUV strain Sotkamo
(Vapalahti et al., 1992), HOKV (Kariwa et al., 1995), TULV
(Tegshduuren et al., 2010) and TPMV (Carey et al., 1971) were
cloned into pET43.1b(þ) (Novagen) for expression as NuSA-
tagged proteins. The MTNV deletion mutants were similarly
prepared (Fig. 1A). Truncated MTNV N protein cDNAs encoding
N1–80, N1–150, N46–125, N125–275, and N250–428 were cloned
into pET32.1b (Novagen) for expression as thioredoxin (TrxA)
fusion proteins (Fig. 1A). For the expression of N protein in
mammalian (Vero E6 and 293T) cells, cDNAs encoding full-length
or deleted MTNV N protein were cloned into the expression
vector pCAGGS/MCS (Niwa et al., 1991).
N. Saasa et al. / Virology 428 (2012) 48–57 55For baculovirus expression, MTNV, CARV, HUIV, SNV 77734
(Botten et al., 2000), BCCV, ANDV, LANV strain 510B, and MAPV,
HTNV, SEOV, PUUV, TULV, TPMV genes encoding full-length N
protein were cloned into pFastBac1 (Invitrogen) and expressed in
High Five cells, as described previously (Koma et al., 2010).
Preparation of recombinant N protein in bacteria
N protein was expressed as a fusion with NuSA or TrxA in
E. coli (strain AD494 pLysS) (Fig. 1). Brieﬂy, transformed cells were
grown in Luria-Bertani medium containing 100 mg/mL ampicillin
to an optical density of A600¼0.6, and expression was induced for
4 h with isopropyl-b-D-thiogalacto-pyranoside to a ﬁnal concen-
tration of 0.5 mM. The cells were recovered by centrifugation
(6000g, 10 min), followed by His-tag afﬁnity puriﬁcation using
ProBond Nickel-chelating resin (Invitrogen) and collection with
Elute Buffer (50 mM Tris, pH 8.0, 0.5 M NaCl, and 250 mM
imidazole) followed by desalting on PD-10 columns (GE Health-
care, Little Chalfont, Buckinghamshire, UK). The recombinant N
proteins were subjected to SDS-PAGE and Western blotting with
the hantavirus N-speciﬁc mAb E5G6 (Yoshimatsu et al., 1996) to
verify correct expression.
Recombinant N protein expression in mammalian systems
For hantavirus N protein expression in mammalian cells,
the entire open reading frame of the S segment or a series of
truncated or deleted constructs encoding the desired regions
were ampliﬁed and cloned into pCAGGS/MCS vector. For IFA,
Vero E6 cells were seeded on 24-well slides and transfected using
TransIT-LT1 transfection reagent (Mirus Bio, Madison, WI, USA).
Cells infected with the following viruses were used: HTNV 76–
118, SEOV SR-11, PUUV Sotkamo strain (Vapalahti et al., 1992),
TULV strain Morabia, and TPMV strain VRC-66412.
The transfected or infected cells were ﬁxed with acetone and
analyzed for reactivity to the mAbs. To prepare an N protein cell
lysate for ELISA and competitive binding assay, 293T cells were
grown in six-well plates and transfected. Expression was carried
out for 48 h. The cells were then harvested and lysed in Lysis
buffer (0.01 M Tris HCl, pH 7.8, 5 mM EDTA, 0.15 M NaCl, 0.6 M
KCl, and 2% Triton X-100).
Mouse immunization
Four-week-old BALB/c mice were inoculated with four doses of
0.2 mL of MTNV N-NuSA (750 mg/mL) in incomplete Freund’s
adjuvant (Rockland, Gilbertsville, PA, USA) at 0-, 14-, 21-, and
48-days intervals. Pre- and post-immune serum was collected
and examined by ELISA for adequate speciﬁc antibody responses.
Four days after the ﬁnal immunization, the mice were sacriﬁced
and their spleens harvested for the preparation of hybridomas.
All experiments involving animals in this study were approved
by the Committee of Animal Experimentation of Hokkaido
University.
Production of mAbs
SP2/0-Ag14 myeloma cells were mixed with the spleen cells
and fused with polyethylene glycol 1500 (Roche, Indianapolis, IN,
USA). The hybridomas were cultured in GIT medium (Nippon
Seiyaku, Osaka, Japan) containing 2 HAT supplement (Gibco-
Invitrogen, Grand Island, USA) and BriClone (NICB, Dublin,
Ireland). MTNV N antibody-secreting hybridomas were cloned at
least four times by limiting dilution. ELISA was used to select
hybridomas producing anti-N protein-speciﬁc antibodies using
MTNV N protein and NuSA (negative control antigen). Next, eight-week-old BALB/c mice were inoculated intraperitoneally with
antibody-producing hybridomas (10107 cells/mouse) and asci-
tic ﬂuid was collected within 2 weeks. The supernatant of the
ascitic ﬂuid was puriﬁed using an Afﬁ-Gel Protein A MAPS II Kit
(BioRad, Hercules, CA, USA) and PD-10 desalting columns. The
mAb IgG subclasses were determined using IsoQuick Strips
(Sigma-Aldrich, St. Louis, MO, USA) according to the manufac-
turer’s protocol.
ELISA
ELISA microtiter plates (NUNC) were coated with recombinant
N protein or NuSA-tagged protein at 2 mg/mL in carbonate-
bicarbonate buffer and left at 37 1C for 1 h or 4 1C overnight.
Block Ace (Dainippon Sumitomo Pharmaceutical, Osaka, Japan)
was used for blocking. The plates were then incubated with
hybridoma culture supernatant or puriﬁed mAbs. After washing,
1:4000-diluted peroxidase-conjugated anti-mouse IgG (Jackson
ImmunoResearch, West Grove, PA, USA) was added to the plate
(50 mL/well). o-phenylenediamine (Sigma-Aldrich) substrate was
applied to the plate (100 mL/well) and left at room temperature
for 30 min. The optical densities were measured at 450–650 nm
using a Labsystem Multiscan MS (Helsinki, Finland). The speciﬁc
reaction was calculated by subtracting the absorbance of the
NuSA tag from the N protein value. All incubations were carried
out for 1 h at 37 1C with three between-step washes using
phosphate-buffered saline containing 0.05% Tween-20 (PBST).
Western blotting
For Western blotting, the N proteins were separated by SDS-
PAGE then transferred to a PVDF membrane (Millipore, Cork,
Ireland). Membrane blocking was performed using Block Ace.
Next, dilute ascitic ﬂuid or puriﬁed mAb (in PBST) was applied,
followed by peroxidase-conjugated IgG (Jackson ImmunoRe-
search). Signals were detected using chemiluminescence ECL
detection reagents (GE Healthcare) according to the manufac-
turer’s protocol.
IFA
Vero E6 cells were seeded on 24-well slides and transfected
with plasmid constructs encoding full-length, truncated, or
deleted N proteins (Fig. 2). Fixed cells were incubated with
10-fold dilutions of puriﬁed mAbs, followed by Alexa-488-con-
jugated anti-mouse IgG antibody (Invitrogen).
Biotinylation and competitive binding assay
The competitive binding assay was performed by a capture
ELISA using a streptavidin-biotin labeled system. Puriﬁed IgG
(2mg) was biotinylated using a Biotin-AC5-OSu Kit (Dojindo
Molecular Technologies, Kumamoto, Japan) according to the man-
ufacturer’s protocol. Next, 96-well plates were coated with 2 mg/mL
mAb (2H10) diluted in PBS, incubated overnight at 4 1C, and
blocked with 3% BSA-PBS buffer. A MTNV N protein lysate prepared
from 293T cells (1:20) was captured for 1 h, followed by the
addition of a 10-fold excess of unlabeled mAb (from 0.1 mg/mL)
in 0.5% BSA (in PBST). Biotin-labeled mAbs were added without
washing, and then the plate was incubated with streptavidin-
peroxidase (Invitrogen) for 30 min at room temperature. The
colorimetric reaction was carried out followed by three washes
with PBST. The absorbance values (450–650 nm) were categorized
as positive (475%), intermediate (25–75%), or negative (o25%)
inhibition in relation to the reference sample without unlabeled/
competing mAbs.
N. Saasa et al. / Virology 428 (2012) 48–5756For the capture ELISA for the detection of baculovirus N
protein in High ﬁve cell lysate, reactivity to mAbs detection was
carried out using biotinylated mAb E5G6.Acknowledgments
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